Cue Biopharma Inc (NAS:CUE)
$ 1.56 -0.09 (-5.45%) Market Cap: 75.88 Mil Enterprise Value: 51.74 Mil PE Ratio: 0 PB Ratio: 2.52 GF Score: 52/100

Cue Biopharma Inc To Host Business Update Call Transcript

Jun 14, 2023 / 08:30PM GMT
Release Date Price: $3.78 (-5.03%)
Operator

Greetings, and welcome to the Cue Biopharma Investor Call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Daniel Passeri, CEO. Thank you, Daniel. You may begin.

Daniel R. Passeri
Cue Biopharma, Inc. - CEO & Director

All right. Thank you, and good afternoon, everyone. As a reminder, this presentation and discussion is being recorded and will be available on our website for the following 30 days. Those listening in may advance slides directly, and we'll notify you which slide we're on and discussing.

Joining me on today's call is Dr. Anish Suri, our President and Chief Scientific Officer; and Dr. Matteo Levisetti, our Chief Medical Officer. As shown here on Slide #2, this presentation and overview may contain some forward-looking statements, and any forward-looking statements made during the call represents the company's views only as of today, June 14, 2023.

After Matteo, I'll return for a brief summary, prior to opening the call up to questions. So first,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot